A diagnosis of AD during life can be greatly aided by measurement of cerebrospinal fluid levels of Aβ1–42, tau, and phosphorylated tau1; and by positron emission tomography detection of radioactive Aβ ligands such as PiB2. Here, MAPT is linked to Alzheimer disease.